Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Iron chelators and ferritinophagy modulators exert protective effects largely through mitochondrial mechanisms
Kailera seeks to differentiate GLP-1/GIP agonist after partners Phase III China data Jiangsu Hengruis HRS9531 shows 17.7% placebo-adjusted weight loss at top dose Data from a Phase III study of HRS9531 in China support Jiangsu Hengruis bid for domestic approval to treat obesity, but fail to clearly differentiate the dual GLP-1/GIP agonist from established or emerging competitors
For quick relief: Osmotic or stimulant laxatives work faster, but they should be used with caution and are not ideal for daily use
Ohwada S, Ikeya T, Yokomori T, et al
US$ 23.98
US$ 24.98
US$ 25.08
US$ 23.53
US$ 25.67
US$ 26.95
